## BACKGROUND. Whereas the embryological development of the human prostate is clearly dependent on steroid 5␣-reductase (5␣-R) type 2 expression, the respective expression of the two known isoforms (types 1 and 2) of 5␣-R in the adult human prostate remains unclear. METHODS. 5␣-R isoform mRNA expr
Presence of 5α-Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue
✍ Scribed by Negri-Cesi, Paola; Poletti, Angelo; Colciago, Alessandra; Magni, Paolo; Martini, Paolo; Motta, Marcella
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 239 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND. Prostate trophism depends on DHT formed from T by the enzyme 5␣-R. Two 5␣-R isoforms with different biochemical characteristics have been cloned. Also estrogens might contribute to the prostate growth; however, their intraglandular formation by the enzyme aromatase is still debated. The aim of the present study was to verify whether (a) only one or both isoforms of the 5␣-Rs are expressed in the prostate cancer cell line LNCaP and in BPH, or (b) the aromatase is present in these samples. METHODS. The profile of the pH optimum of the 5␣-Rs was evaluated ''in vitro'' in LNCaP cells by the production of labeled 5␣-reduced metabolites either from [ 14 C]-T or [ 14 C]-D4 at pH 3.5-8. The gene expression of the two 5␣-Rs and of the aromatase in LNCaP cells and in BPH specimens was analyzed by RT-PCR combined to Southern blot analysis, using specific sets of oligonucleotides. The tissue localization of 5␣-R1 was analyzed by immunohistochemistry using an anti-5␣-R1 polyclonal antibody. RESULTS. (a) In LNCaP cells, the formation of 5␣-reduced metabolites from the respective precursors increases progressively as a function of pH, being the highest at neutral pH values; (b) the 5␣-R1 isoform is expressed in both LNCaP cells and in BPH, while the 5␣-R2 mRNA is present only in BPH, but not in LNCaP cells; and (c) no aromatase transcripts were observed either in BPH or in LNCaP cells. CONCLUSIONS. A careful examination of the possible differential expression of T-activating enzymes, particularly in prostate cancer, would be of help to choose the appropriate treatment.
📜 SIMILAR VOLUMES
The aim of this study on testosterone (T) metabolism in benign prostatic hyperplasia (BPH) and prostatic cancer was to compare the formation of metabolites in freshly isolated epithelial cells and in cells of long-term cultures (2 passages) and to identify the 5alpha-reductase (5alpha-R) and 17beta-
## Background: The presence and possible role of androgen-metabolizing enzymes in androgen-independent prostate carcinoma (cap) are still unclear. the aim of the present study was: 1) to evaluate the pattern of androgen metabolism (relative production of 5alpha-reduced vs. 17-keto androgens); and 2
## BACKGROUND. The dog has been extensively used as an in vivo model to test the pharmacokinetics and effects on pathological prostatic growth of 5␣-reductase inhibitors. However, no information is available on the existence or characteristics of canine 5␣-reductase isozymes. METHODS. The 5␣-reduc
## Background: Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the dunning r3327 rat prostatic carcinoma model. we evaluated the preventive effect of turosteride when administered during the latency period in this p
BACKGROUND. We analyzed the cytotoxic properties of the new heterodinucleoside phosphate dimer 5-FdU-NOAC, which is composed of the cytotoxic drugs 5-FdU and N 4octadecyl-1--D-arabinofuranosylcytosine (NOAC) against human prostate tumor cells. METHODS. 5-FdU-NOAC effects on cell proliferation, cell